Published in Cell Immunol on February 01, 1997
Selection of self-reactive T cells in the thymus. Annu Rev Immunol (2011) 1.98
An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells. Nat Immunol (2009) 1.78
A constant affinity threshold for T cell tolerance. J Exp Med (2007) 1.36
An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol (2004) 1.28
Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms. J Immunol (2009) 0.84
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol (2001) 5.15
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature (1996) 3.08
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05
Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol (2001) 2.76
Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med (1993) 2.57
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut (1987) 1.79
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J Exp Med (1996) 1.66
Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes. J Exp Med (1995) 1.57
Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature (1989) 1.52
Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. J Immunol (1989) 1.49
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias. J Virol (1995) 1.40
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35
The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur J Immunol (1990) 1.30
Expression of two T cell receptor alpha chains on the surface of normal murine T cells. Eur J Immunol (1995) 1.27
Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Eur J Immunol (1993) 1.24
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature (1999) 1.23
Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity (2000) 1.22
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens (2006) 1.20
MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity (2001) 1.18
Antigen-specific CD8+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur J Immunol (1997) 1.18
T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs. J Exp Med (1999) 1.15
Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect Immun (1993) 1.14
Processing of a minimal antigenic peptide alters its interaction with MHC molecules. Nature (1988) 1.12
Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10
Immunity or tolerance? That is the question for dendritic cells. Nat Immunol (2001) 1.09
Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol (1994) 1.08
Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J Virol (2000) 1.07
Cytotoxic T lymphocyte activation by cross-priming. Curr Opin Immunol (1999) 1.07
Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells. J Exp Med (1992) 1.06
TCR alpha-chain usage can determine antigen-selected TCR beta-chain repertoire diversity. J Immunol (1996) 1.03
Conformational difference of T cell antigen receptors revealed by monoclonal antibodies to mouse V beta 5 T cell receptor for antigen determinants. J Immunol (1991) 1.01
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol (2000) 1.01
A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol (2001) 1.01
Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (1993) 1.00
Monoclonal antibodies to horse cytochrome c expressing four distinct idiotypes distribute among two sites on the native protein. J Immunol (1985) 1.00
Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus. J Gen Virol (2000) 0.96
Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes. J Immunol (1989) 0.96
The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant. J Immunol (1988) 0.96
Deletion of high-avidity T cells by thymic epithelium. Proc Natl Acad Sci U S A (1995) 0.95
The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol (1998) 0.95
Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes (2001) 0.94
The use of hydrophobic, alpha-helix-defined peptides in delineating the T cell determinant for pigeon cytochrome c. J Immunol (1987) 0.93
Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J Exp Med (1994) 0.90
Murine AIDS superantigen reactivity of the T cells bearing V beta 5 T cell antigen receptor. J Immunol (1992) 0.90
Inhibition of naïve class I-restricted T cells by altered peptide ligands. Immunol Cell Biol (1999) 0.89
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines. Eur J Immunol (2000) 0.87
Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int Immunol (1997) 0.87
Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity. Novartis Found Symp (1998) 0.86
Two large immunogenic and antigenic myoglobin peptides and the effects of cyclisation. Mol Immunol (1985) 0.86
Peptide presentation by class-I major histocompatibility complex molecules. Immunol Res (1991) 0.85
Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. Int Immunol (1997) 0.84
A dominant V beta bias in the CTL response after HSV-1 infection is determined by peptide residues predicted to also interact with the TCR beta-chain CDR3. Mol Immunol (1998) 0.84